MAPT and Alzheimer disease: Astrogliosis, beneficial and impaired clearance of amyloid and tau proteins, the secretion of neurotoxic and proinflammatory agents, synaptic phagocytosis, impaired synaptic homeostasis, and BBB disruption are remarkable astrocytic toxic changes manifested in early AD.